Clal Biotechnology reported ILS6.66M in Current Liabilities for its fiscal quarter ending in December of 2023.


Current Liabilities Change Date
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.58M 420K Jun/2025
Life Technologies USD 15.53M 563K Jun/2025
RedHill Biopharma USD 22.22M 993K Dec/2024